177 studies found for:    "Osteoporosis, Postmenopausal"
Show Display Options
Rank Status Study
1 Completed Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: Recombinant Salmon Calcitonin
2 Recruiting Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: E2 transdermal (Julina, BAY86-5435)
3 Completed 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: Teriparatide;   Drug: Raloxifene
4 Completed Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment
Condition: Osteoporosis, Postmenopausal
Intervention: Other: OPSAT-Q
5 Completed Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: ibandronate, calcium and vitamin D;   Drug: placebo,calcium and vitamin D
6 Completed Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women
Conditions: Osteoporosis;   Bone Loss, Age Related;   Postmenopausal Bone Loss;   Postmenopausal Osteoporosis
Intervention: Behavioral: Osteoporosis Choice Decision Aid
7 Completed Julina Post-marketing Surveillance for Climacteric Symptoms in Japan
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: E2 transdermal (Julina, BAY86-5435)
8 Completed Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis
Conditions: Postmenopausal Osteoporosis;   Compliance
Interventions: Drug: Raloxifene;   Drug: Strontium ranelate
9 Active, not recruiting Study With AMG 785 to Treat Japanese Women With Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis (PMO)
Interventions: Drug: AMG 785;   Drug: Placebo
10 Completed Risedronate Sodium in Post Menopausal Osteoporosis
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: risedronate sodium
11 Completed
Has Results
Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: AMG 162;   Drug: Placebo
12 Enrolling by invitation Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Intervention: Other: Observation
13 Completed
Has Results
Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women
Condition: Postmenopausal Osteoporosis
Interventions: Drug: menatetranone;   Drug: alfacalcidol
14 Completed Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Intervention: Drug: Ibandronate (SB743830HD)
15 Completed BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
16 Active, not recruiting A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosis
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
17 Completed Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: disodium clodronate 200 mg/4 ml with 1% lidocaine;   Drug: Disodium clodronate 100 mg/3,3 ml with 1% lidocaine
18 Completed ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
19 Completed A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
20 Completed BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years